Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (2,240) Arrow Down
Filter Results: (2,240) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (4,846)
    • People  (16)
    • News  (1,870)
    • Research  (2,240)
    • Events  (2)
    • Multimedia  (220)
  • Faculty Publications  (1,830)

Show Results For

  • All HBS Web  (4,846)
    • People  (16)
    • News  (1,870)
    • Research  (2,240)
    • Events  (2)
    • Multimedia  (220)
  • Faculty Publications  (1,830)
← Page 94 of 2,240 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • 2018
  • Working Paper

Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices

By: Prithwiraj Choudhury and Tarun Khanna
We exploit a natural experiment to study how codifying information about prior innovation affects subsequent innovation. A codified database of traditional Indian herbal formulations was adopted by the European Patent Office (EPO) and the U.S. Patent and Trademark... View Details
Keywords: Patents; Plant-Based Agribusiness; Ethnicity; Health Care and Treatment; Pharmaceutical Industry; Agriculture and Agribusiness Industry; China; India
Citation
Read Now
Related
Choudhury, Prithwiraj, and Tarun Khanna. "Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices." Harvard Business School Working Paper, No. 14-079, February 2014. (Revised January 2018.)
  • 23 Feb 2016
  • First Look

February 23, 2016

https://www.hbs.edu/faculty/Pages/item.aspx?num=50625 February 2016 Harvard Business Review The Harvard Contest That’s Trying to Improve Health Care Delivery By: Hamermesh, Richard G., Robert S. Huckman,... View Details
Keywords: Sean Silverthorne
  • June 2015 (Revised May 2017)
  • Teaching Note

Philips Healthcare: Marketing the HealthSuite Digital Platform

By: John A. Quelch
Keywords: Healthcare; Experiential Quality; Conformance Quality; Clinical Outcomes; Cost Efficiency; Quality; Performance; Health Care and Treatment
Citation
Purchase
Related
Quelch, John A. "Philips Healthcare: Marketing the HealthSuite Digital Platform." Harvard Business School Teaching Note 515-113, June 2015. (Revised May 2017.)
  • December 1986 (Revised July 1989)
  • Background Note

Note on the Hospital Information Systems Industry

By: Regina E. Herzlinger
Keywords: Information Technology; Health Care and Treatment
Citation
Find at Harvard
Related
Herzlinger, Regina E. "Note on the Hospital Information Systems Industry." Harvard Business School Background Note 187-092, December 1986. (Revised July 1989.)
  • 2009
  • Working Paper

Input Constraints and the Efficiency of Entry: Lessons from Cardiac Surgery

By: David M. Cutler, Robert S. Huckman and Jonathan T. Kolstad
Prior studies suggest that, with elastically supplied inputs, free entry may lead to an inefficiently high number of firms in equilibrium. Under input scarcity, however, the welfare loss from free entry is reduced. Further, free entry may increase use of high-quality... View Details
Keywords: Health Care and Treatment; Market Entry and Exit; Duopoly and Oligopoly; Government Legislation; Mathematical Methods; Health Industry; Pennsylvania
Citation
Related
Cutler, David M., Robert S. Huckman, and Jonathan T. Kolstad. "Input Constraints and the Efficiency of Entry: Lessons from Cardiac Surgery." NBER Working Paper Series, No. 15214, August 2009.
  • June 2019
  • Teaching Note

Zebra Medical Vision

By: Shane Greenstein and Sarah Gulick
Teaching note is meant to accompany Zebra Medical Vision case, which offers a look at a company’s decisions as a small startup competing with other startups and major technology companies. It also demonstrates the challenges faced by a machine learning company working... View Details
Keywords: Business Startups; Science-Based Business; Applications and Software; Patents; Cross-Cultural and Cross-Border Issues; Health Care and Treatment; Health Industry; Health Industry; Health Industry; Israel
Citation
Purchase
Related
Greenstein, Shane, and Sarah Gulick. "Zebra Medical Vision." Harvard Business School Teaching Note 619-053, June 2019.
  • 29 Sep 2015
  • First Look

September 29, 2015

multitude of complex problems plaguing the U.S. health system. The United States over the last 50 years has focused most of its health resources on providing medical care for... View Details
Keywords: Sean Silverthorne
  • January 2007
  • Article

A Randomized Clinical Trial of EMDR, Fluoxetine and Pill Placebo in the Treatment of PTSD: Treatment Effects and Long-term Maintenance

By: Bessel A. van der Kolk, Joseph Spinazzola, Margaret E. Blaustein, James Hopper, Elizabeth Hopper, Deborah Korn and William B. Simpson
Keywords: Health Testing and Trials; Health Care and Treatment; Health Disorders
Citation
Find at Harvard
Related
van der Kolk, Bessel A., Joseph Spinazzola, Margaret E. Blaustein, James Hopper, Elizabeth Hopper, Deborah Korn, and William B. Simpson. "A Randomized Clinical Trial of EMDR, Fluoxetine and Pill Placebo in the Treatment of PTSD: Treatment Effects and Long-term Maintenance." Journal of Clinical Psychiatry 68, no. 1 (January 2007).
  • June 2024
  • Supplement

Legacy Partners (B)

By: Richard S. Ruback and Royce Yudkoff
Pre-abstract: Instructors should consider the timing of making videos available to students, as they may reveal key case details.

Abstract: Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six... View Details
Keywords: Acquisition; Small Business; Cost vs Benefits; Decisions; Business Education; Corporate Entrepreneurship; Leadership Style; Leading Change; Business or Company Management; Problems and Challenges; Health Care and Treatment; Health Disorders; Medical Specialties; Nutrition; Supply Chain Management; Growth Management; Health Industry; Health Industry; United States; California
Citation
Purchase
Related
Ruback, Richard S., and Royce Yudkoff. "Legacy Partners (B)." Harvard Business School Multimedia/Video Supplement 224-726, June 2024.
  • January 2025
  • Supplement

The VideaHealth AI Factory: CEO Florian Hillen on Speed, Scale, and Innovation (B)

By: Tsedal Neeley, Levi Stroud, Ruth Page and Dave Habeeb
Pre-abstract: This multimedia case should be assigned to students in advance of class. Instructors should consider the timing of making the (B) Case videos available to students, as they may reveal key case details.

Abstract: Florian Hillen, co-founder... View Details
Keywords: Diagnostics; Organization Design; Change Management; Disruption; Transformation; Health Care and Treatment; AI and Machine Learning; Technology Adoption; Technological Innovation; Management Style; Organizational Culture; Success; Health Industry; Health Industry; United States
Citation
Purchase
Related
Neeley, Tsedal, Levi Stroud, Ruth Page, and Dave Habeeb. "The VideaHealth AI Factory: CEO Florian Hillen on Speed, Scale, and Innovation (B)." Harvard Business School Multimedia/Video Supplement 425-721, January 2025.
  • January 2025
  • Case

The VideaHealth AI Factory: CEO Florian Hillen on Speed, Scale, and Innovation (A)

By: Tsedal Neeley, Levi Stroud, Ruth Page and Dave Habeeb
Pre-abstract: This multimedia case should be assigned to students in advance of class. Instructors should consider the timing of making the (B) Case videos available to students, as they may reveal key case details.

Abstract: Florian Hillen, co-founder... View Details
Keywords: Diagnostics; Organization Design; Change Management; Disruption; Transformation; Health Care and Treatment; AI and Machine Learning; Technology Adoption; Technological Innovation; Management Style; Organizational Culture; Success; Health Industry; Health Industry; United States
Citation
Educators
Purchase
Related
Neeley, Tsedal, Levi Stroud, Ruth Page, and Dave Habeeb. "The VideaHealth AI Factory: CEO Florian Hillen on Speed, Scale, and Innovation (A)." Harvard Business School Multimedia/Video Case 425-720, January 2025.
  • June 2010
  • Teaching Note

American Well: The Doctor Will E-See You Now (TN)

By: Elie Ofek
Teaching Note for 510061. View Details
Keywords: Health Care and Treatment; Information Technology; Innovation and Invention; Online Technology; Revenue; System; Opportunities; Technology Adoption; Growth and Development; Brands and Branding; Business Model; Health Industry; United States
Citation
Purchase
Related
Ofek, Elie. "American Well: The Doctor Will E-See You Now (TN)." Harvard Business School Teaching Note 510-125, June 2010.
  • June 2010 (Revised August 2010)
  • Case

Dr. Cameron Powell and AirStrip Technologies: After the Apple Worldwide Developers Conference

Dr. Cameron Powell and his partner, Trey Moore, co-founders of the innovative company, AirStrip Technologies, have developed a series of apps for the iPhone and other smartphones that can help doctors monitor the vital signs of their patients anytime, anywhere. They... View Details
Keywords: Information Technology; Entrepreneurship; Applications and Software; Health Care and Treatment; Mobile and Wireless Technology; Product Development; Health Industry; Health Industry; United States
Citation
Educators
Purchase
Related
Chakravorti, Bhaskar, and N. Venkatraman. "Dr. Cameron Powell and AirStrip Technologies: After the Apple Worldwide Developers Conference." Harvard Business School Case 810-143, June 2010. (Revised August 2010.)
  • 22 Feb 2021
  • Working Paper Summaries

Private and Social Returns to R&D: Drug Development and Demographics

Keywords: by Efraim Benmelech, Janice Eberly, Dimitris Papanikolaou, and Joshua Krieger; Pharmaceutical
  • April 1998
  • Case

Cephalon, Inc.

By: Peter Tufano
In early 1997, Cephalon, awaited an FDA panel's decision on whether its drug, Myotrophin, would be approved. If the drug was approved, the firm might need substantial additional funds to commercialize as well as to buy back rights to it (which had been sold earlier to... View Details
Keywords: Risk Management; Financing and Loans; Health Care and Treatment; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Tufano, Peter, Geoffrey Verter, and Markus Mullarkey. "Cephalon, Inc." Harvard Business School Case 298-116, April 1998.
  • May 4, 2023
  • Article

Falling Insulin Prices—What Just Happened?

By: Leemore S. Dafny
Recently, more than 100 years after insulin was developed, manufacturers announced price reductions for insulin products. Pressure to reduce prices had long been building, so why would they act now? View Details
Keywords: Price; Health Care and Treatment; Public Opinion; Demand and Consumers; Pharmaceutical Industry
Citation
Find at Harvard
Register to Read
Related
Dafny, Leemore S. "Falling Insulin Prices—What Just Happened?" New England Journal of Medicine 388, no. 18 (May 4, 2023): 1636–1639.
  • April 2006 (Revised May 2009)
  • Case

Inverness Medical Innovations - Born Global (A)

Ron Zwanziger has just started his third company, having just sold the last one for $1.3 billion to Johnson & Johnson. As part of the deal with J&J, certain assets were transferred to the new company, Inverness Medical Innovations, which, at the time of its creation,... View Details
Keywords: Globalized Firms and Management; Mergers and Acquisitions; Entrepreneurship; Health Care and Treatment; Corporate Finance; Health Industry; Health Industry; Waltham
Citation
Educators
Purchase
Related
Isenberg, Daniel J. "Inverness Medical Innovations - Born Global (A)." Harvard Business School Case 806-177, April 2006. (Revised May 2009.)
  • September 2013
  • Article

Testimonials Do Not Convert Patients from Brand to Generic Medication

By: John Beshears, James J. Choi, David Laibson, Brigitte C. Madrian and Gwendolyn Reynolds

Objectives: To assess whether the addition of a peer testimonial to an informational mailing increases conversion rates from brand name prescription medications to lower-cost therapeutic equivalents, and whether the testimonial's efficacy increases when... View Details

Keywords: Testimonial; Peer Information; Social Proximity; Communication; Generic Medication; Familiarity; Marketing Communications; Decision Choices and Conditions; Identity; Health Care and Treatment; Marketing Reference Programs; Power and Influence; Brands and Branding; Health Industry
Citation
Read Now
Related
Beshears, John, James J. Choi, David Laibson, Brigitte C. Madrian, and Gwendolyn Reynolds. "Testimonials Do Not Convert Patients from Brand to Generic Medication." American Journal of Managed Care 19, no. 9 (September 2013): e314–e316.
  • March 2022 (Revised March 2024)
  • Case

DaVita Responds to COVID

By: Susanna Gallani and David Lane
Early in August 2021, DaVita CEO Javier Rodriguez was assessing the ongoing impact of the COVID-19 pandemic on his firm, which provided life-sustaining kidney dialysis to roughly 240,000 people. Effective infection control practices and information sharing had ensured... View Details
Keywords: COVID-19 Pandemic; Change Management; Communication; Talent and Talent Management; Fairness; Values and Beliefs; Corporate Accountability; Health Care and Treatment; Health Pandemics; Human Resources; Employee Relationship Management; Retention; Wages; Working Conditions; Leadership Style; Crisis Management; Organizational Culture; Health Industry; United States
Citation
Educators
Purchase
Related
Gallani, Susanna, and David Lane. "DaVita Responds to COVID." Harvard Business School Case 122-007, March 2022. (Revised March 2024.)
  • 2008
  • Case

Eli Lilly: Recreating Drug Discovery for the 21st Century

By: Rebecca Henderson and C. Reavis
Keywords: Innovation and Invention; Health Care and Treatment; Pharmaceutical Industry
Citation
Related
Henderson, Rebecca, and C. Reavis. "Eli Lilly: Recreating Drug Discovery for the 21st Century." Massachusetts Institute of Technology (MIT) Case, 2008.
  • ←
  • 94
  • 95
  • …
  • 111
  • 112
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.